Research

Leading the Way

Asheville Gastroenterology Associates is currently engaged in the following clinical trials. If you or someone you know, is over 18 years of age and are interested in any of our current clinical trials listed, you may contact us for more information to see if you qualify. If eligible, most trials will cover the cost of trial-related expenses and/or stipend. Email research@ashevillegastro.com your contact information and a study coordinator will contact you.


IBD- Ulcerative Colitis studies:

1) A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)

Read More

2) A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Subjects With Ulcerative Colitis (UC)

Read More

3) A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Read More

4) A Study to Assess Efficacy and Safety of SER‑287 in Adults With Active Mild-to-Moderate Ulcerative Colitis (ECO-RESET)

Read More

5) Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study (TOUR)

Read More

6) ROBARTS-“VERDICT” FOR UC- RANDOMIZED TRIAL TO DETERMINE OPTIMAL TREATMENT TARGET- CONTACT KELLY ROBERTS #3427  To Be Announced


IBD- Crohn’s Disease studies:

1) Ozanimod is under clinical investigation and has not been approved by the U.S. Food and Drug Administration or other regulatory agencies for any indication.

Read More

2) A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease (GALAXI)

Read More

3) Triple Combination Therapy in High Risk Crohn's Disease (CD)

Read More

Colon Cancer Screening studies:

1) Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast.

Read More

2) Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening “BLUE-C"

Read More

3) Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode (ECLIPSE)

Read More

Liver Disease Screening studies:

1) Drug-Induced Liver Injury (DILN)Network Retrospective (ILIAD)

Read More

2) Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) (RESOLVE-IT)

Read More

3) HOME ACCESS HEALTH- ELEVATED AST >200- BLOOD ASSAY COMPARISON-WRH- CONTACT AMBER BARTLETT #3562  (Blood Assay only)


GERD studies:

1) Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors

Read More

Gastroparesis studies:

1) A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01

Read More

Celiac studies:

1) Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms

Read More

Bowel Prep studies:

1) BRAINTREE- BOWEL PREP-COMPARISON OF SAFETY/EFFICACY VS COMPARATOR AS 2-DAY, SPLIT PREP-CONTACT KELLY ROBERTS #3427  (To Be Announced)


Miscellaneous studies:

1) SEER-020102-BLOOD SAMPLE STUDY FOR MULTIPLE DISEASE STATES- CONTACT AMBER BARTLETT #3562 (Sample Collection only)


COMING SOON!

1) EoE TREATMENT STUDY- CONTACT KYLEE DIAZ #3426

Take Control of Your Health

Whether you are looking for preventative care for colon cancer screening or seeking diagnosis and treatment for a gastrointestinal condition, we can help. We provide consultative and procedural services spanning the full spectrum of clinical gastroenterology and hepatology.

Navigation